THMO (ThermoGenesis Holdings) WACC %:81.42% (As of Jun. 30, 2026)


THMO ThermoGenesis Holdings Inc THMO
16 GF Score
Price $0.00
View Full Analysis

What is ThermoGenesis Holdings WACC %?

ThermoGenesis Holdings THMO 16 WACC % is 81.42% as of Jun. 30, 2026. GuruFocus rates THMO with a GF Score™ of 16/100.

As of today (2026-06-30), ThermoGenesis Holdings's weighted average cost of capital is 81.42%%. ThermoGenesis Holdings's ROIC % is 0.00% (calculated using TTM income statement data). ThermoGenesis Holdings earns returns that do not match up to its cost of capital. It will destroy value as it grows.

For a comprehensive WACC calculation, please access the WACC Calculator.


ThermoGenesis Holdings  (OTCPK:THMO) WACC % Explanation

Because it costs money to raise capital. A firm that generates higher ROIC % than it costs the company to raise the capital needed for that investment is earning excess returns. A firm that expects to continue generating positive excess returns on new investments in the future will see its value increase as growth increases, whereas a firm that earns returns that do not match up to its cost of capital will destroy value as it grows.

As of today, ThermoGenesis Holdings's weighted average cost of capital is 81.42%%. ThermoGenesis Holdings's ROIC % is 0.00% (calculated using TTM income statement data). ThermoGenesis Holdings earns returns that do not match up to its cost of capital. It will destroy value as it grows.


Be Aware

1. GuruFocus uses book value of debt (D) to do the calculation. It is simplified by adding latest one-year quarterly average Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation together.
For companies that report quarterly, GuruFocus combines all of the most recent year's quarterly debt data from the beginning of the year to the year-end and calculates the average.
For companies that report semi-annually, GuruFocus combines all of the most recent year's semi-annual debt data from the start of the year to the year-end and calculates the average.
For companies that report annually, GuruFocus combines the beginning and ending annual debt data from the most recent year and then calculates the average.

2. The WACC formula discussed above does not include Preferred Stock. Please adjust if preferred stock is considered.

3. (Expected Return of the Market - Risk-Free Rate of Return) is also called market premium. GuruFocus requires market premium to be 6%.

4. GuruFocus uses the latest TTM Interest Expense divided by the latest one-year quarterly average debt to get the simplified cost of debt.


Related Terms

ThermoGenesis Holdings WACC % Historical Data

* Premium members only.

The historical data trend for ThermoGenesis Holdings's WACC % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

ThermoGenesis Holdings WACC % Chart

ThermoGenesis Holdings Annual Data
Trend Jun14 Jun15 Jun16 Jun17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
WACC %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 35.84 48.28 41.86 45.64 83.63

ThermoGenesis Holdings Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
WACC % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 66.48 61.92 64.55 83.63 54.54

THMO vs MSIU, MOTS, ABT: WACC % Comparison

For the Medical Devices subindustry, ThermoGenesis Holdings's WACC %, along with its competitors' market caps and WACC % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


ThermoGenesis Holdings WACC % vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, ThermoGenesis Holdings's WACC % distribution charts can be found below:

* The bar in red indicates where ThermoGenesis Holdings's WACC % falls into.


THMO
16GF Score
ThermoGenesis Holdings Inc THMO
WACC % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

ThermoGenesis Holdings WACC % Calculation

The weighted average cost of capital (WACC) is the rate that a company is expected to pay on average to all its security holders to finance its assets. The WACC is commonly referred to as the firm's cost of capital. Generally speaking, a company's assets are financed by debt and equity. WACC is the average of the costs of these sources of financing, each of which is weighted by its respective use in the given situation. By taking a weighted average, we can see how much interest the company has to pay for every dollar it finances.

WACC=E/(E + D)*Cost of Equity+D/(E + D)*Cost of Debt*(1 - Tax Rate)

1. Weights:
Generally speaking, a company's assets are financed by debt and equity. We need to calculate the weight of equity and the weight of debt.
The market value of equity (E) is also called "Market Cap". As of today, ThermoGenesis Holdings's market capitalization (E) is $0.002 Mil.
The market value of debt is typically difficult to calculate, therefore, GuruFocus uses book value of debt (D) to do the calculation. It is simplified by adding the latest one-year quarterly average Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation together. As of Mar. 2024, ThermoGenesis Holdings's latest one-year quarterly average Book Value of Debt (D) is $9.3088 Mil.
a) weight of equity = E / (E + D) = 0.002 / (0.002 + 9.3088) = 0.0002
b) weight of debt = D / (E + D) = 9.3088 / (0.002 + 9.3088) = 0.9998

2. Cost of Equity:
GuruFocus uses Capital Asset Pricing Model (CAPM) to calculate the required rate of return. The formula is:
Cost of Equity = Risk-Free Rate of Return + Beta of Asset * (Expected Return of the Market - Risk-Free Rate of Return)
a) GuruFocus uses 10-Year Treasury Constant Maturity Rate as the risk-free rate. It is updated daily. The current risk-free rate is 4.465%. Please go to Economic Indicators page for more information. Please note that we use the 10-Year Treasury Constant Maturity Rate of the country/region where the company is headquartered. If the data for that country/region is not available, then we will use the 10-Year Treasury Constant Maturity Rate of the United States as default.
b) Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. ThermoGenesis Holdings's beta is -5.2761.
c) (Expected Return of the Market - Risk-Free Rate of Return) is also called market premium. GuruFocus requires market premium to be 6%.
Cost of Equity = 4.465% + -5.2761 * 6% = -27.1916%

3. Cost of Debt:
GuruFocus uses latest TTM Interest Expense divided by the latest one-year quarterly average debt to get the simplified cost of debt.
As of Mar. 2024, ThermoGenesis Holdings's interest expense (positive number) was $7.581 Mil. Its total Book Value of Debt (D) is $9.3088 Mil.
Cost of Debt = 7.581 / 9.3088 = 81.4391%.

4. Multiply by one minus TTM Tax Rate:
GuruFocus uses the most recent TTM Tax Expense divided by the most recent TTM Pre-Tax Income to calculate the tax rate. The calculated TTM tax rate is limited to between 0% and 100%. If the calculated tax rate is higher than 100%, it is set to 100%. If the calculated tax rate is less than 0%, it is set to 0%.
The latest calculated TTM Tax Rate = 0 / -15.738 = 0%.

ThermoGenesis Holdings's Weighted Average Cost Of Capital (WACC) for Today is calculated as:

WACC=E / (E + D)*Cost of Equity+D / (E + D)*Cost of Debt*(1 - Tax Rate)
=0.0002*-27.1916%+0.9998*81.4391%*(1 - 0%)
=81.42%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about WACC % →
What does a WACC % of 81.42% mean?
ThermoGenesis Holdings (THMO) has a WACC % of 81.42% as of Jun. 30, 2026. The weighted average cost of capital (WACC) is the average rate a company pays to finance assets. View historical data on ThermoGenesis Holdings and its competitors.
Is ThermoGenesis Holdings' WACC % too high?
ThermoGenesis Holdings' current WACC % is 81.42%. The Medical Devices & Instruments industry median WACC % is 9.23. ThermoGenesis Holdings' value of 81.42% is 782.1% above this industry median. Overall, ThermoGenesis Holdings has a GF Score™ of 16/100, reflecting its overall financial health beyond just this single metric.
How does ThermoGenesis Holdings' WACC % compare to MSIU and MOTS?
ThermoGenesis Holdings' WACC % of 81.42% can be compared against companies in the Medical Devices & Instruments industry. The industry median WACC % is 9.23. ThermoGenesis Holdings' value of 81.42% is 782.1% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good WACC % for a Medical Devices & Instruments company?
The median WACC % among Medical Devices & Instruments companies is 9.23, based on 866 companies in the industry. Companies in the top quartile (top 25%) have a WACC % significantly above this median, while those in the bottom quartile fall well below. However, WACC % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. ThermoGenesis Holdings's current WACC % of 81.42% is 782.1% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high WACC % mean?
A high WACC % can signal that a stock is expensive relative to its fundamentals. The weighted average cost of capital (WACC) is the average rate a company pays to finance assets. View historical data on ThermoGenesis Holdings and its competitors. For the Medical Devices & Instruments industry, the median WACC % is 9.23 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. ThermoGenesis Holdings's current WACC % is 81.42%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is ThermoGenesis Holdings stock overvalued right now?
ThermoGenesis Holdings (THMO) has a current WACC % of 81.42%. The current WACC % is 81.42% and 782.1% above the Medical Devices & Instruments industry median of 9.23. ThermoGenesis Holdings' overall GF Score™ is 16/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is WACC % calculated?
WACC % is calculated from a company's financial statements. For ThermoGenesis Holdings (THMO), the current WACC % is 81.42% as of Jun. 30, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

ThermoGenesis Holdings Business Description

Address 2711 Citrus Road, Rancho Cordova, CA, USA, 95742
ThermoGenesis Holdings Inc develops, commercializes and markets a range of automated technologies for CAR-T and other cell-based therapies. The company markets a full suite of solutions for automated clinical biobanking, point-of-care applications, and automation for immuno-oncology, including its semi-automated, functionally-closed CAR-TXpress platform, which streamlines the manufacturing process for the emerging CAR-T immunotherapy market. It offers the AutoXpress and BioArchive platforms for automated clinical bio-banking, PXP platform for point-of-care cell-based therapies and CAR-TXpress platform for bio-manufacturing for immuno-oncology applications.
16GF Score

Get the complete analysis for THMO

WACC % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.00
Price